Ausgabe 4/2013
Inhalt (12 Artikel)
Follistatin as potential therapeutic target in prostate cancer
Maria Vittoria Sepporta, Francesca Maria Tumminello, Carla Flandina, Marilena Crescimanno, Marco Giammanco, Maurizio La Guardia, Danila di Majo, Gaetano Leto
GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78
Florence Delie, Patrick Petignat, Marie Cohen
High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer
Motohiro Imano, Tatsuki Itoh, Takao Satou, Atsushi Yasuda, Kohei Nishiki, Hiroaki Kato, Osamu Shiraishi, Ying-Feng Peng, Masayuki Shinkai, Masahiro Tsubaki, Takushi Yasuda, Haruhiko Imamoto, Shozo Nishida, Yoshifumi Takeyama, Hiroshi Furkawa, Kiyokata Okuno, Hitoshi Shiozaki
Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer
Katsuhiko Shimizu, Takuro Yukawa, Yuji Hirami, Riki Okita, Shinsuke Saisho, Ai Maeda, Koichiro Yasuda, Masao Nakata
Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study
Olivier Trédan, Isabelle Treilleux, Qing Wang, Nicolas Gane, Daniel Pissaloux, Nathalie Bonnin, Thierry Petit, Jacques Cretin, Nathalie Bonichon-Lamichhane, Frank Priou, Sandrine Lavau-Denes, Véronique Mari, Gilles Freyer, Daniela Lebrun, Jérôme Alexandre, Isabelle Ray-Coquard
Prognostic and therapeutic relevance of the IGF pathway in Ewing’s sarcoma patients
A. C. M. van de Luijtgaarden, Y. M. H. Versleijen-Jonkers, M. H. S. Roeffen, H. W. B. Schreuder, U. E. Flucke, W. T. A. van der Graaf
Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas
Hiba el Sayadi, Daniel Pissaloux, Laurent Alberti, Severine Tabone-Eglinger, Dominique Ranchere, Anne Valérie Decouvelaere, Eric Tabone, Isabelle Ray-Coquard, Christophe Caux, Jérome Fayette, Jean-Yves Blay
Gastric cancer (GC) patients with hedgehog pathway activation: PTCH1 and GLI2 as independent prognostic factors
Su Jin Lee, In-Gu Do, Jeeyun Lee, Kyoung-Mee Kim, Jiryeon Jang, Insuk Sohn, Won Ki Kang
Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro
Miklos Jaszberenyi, Andrew V. Schally, Norman L. Block, Marta Zarandi, Ren-Zhi Cai, Irving Vidaurre, Luca Szalontay, Arumugam R. Jayakumar, Ferenc G. Rick
Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer
Fausto Petrelli, Karen Borgonovo, Veronica Lonati, Stefano Elia, Sandro Barni
Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications
A. Italiano, E. Saada, A. Cioffi, S. Poulette, S. Bouchet, M. Molimard, A. Adenis, N. Isambert, O. Collard, Axel Le Cesne, Robert G. Maki, B. Bui
Erratum to: Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma
Andres Morales La Madrid, Nicholas Campbell, Sonali Smith, Susan L. Cohn, Ravi Salgia